Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

44.86 +1.58 (+3.65%)
Streaming Delayed Price Updated: 11:30 AM EDT, Mar 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Cathie Wood's Ark Invest Purchases Over $30M of Shopify Shares Amid Q1 Numbers-Driven Plunge; Adds Reddit Shares To Kitty — Offloads Coinbase Stock As Bitcoin Declines ↗
On Wednesday, Cathie Wood’s Ark Invest made some significant trades. 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Swoops In To Buy The Palantir Dip — Purchases Stock Worth $29M — Offloads Coinbase Shares Worth Over $15M Amid Softening Bitcoin Price ↗
On Tuesday, the Cathie Wood-led Ark Invest made some significant trades. 
Via Benzinga
News headline image
Breaking Down Twist Bioscience: 5 Analysts Share Their Views ↗
 
Via Benzinga
News headline image
Genomics firm Twist Bioscience's Momentum To Continue Throughout 2024, Analyst Says ↗
Twist Bioscience reports strong Q2 earnings, with sales up 25% YoY to $75.3M and orders increasing by 45%. Gross margin expands to 41%. Fiscal year guidance was raised, and William Blair sees continued... 
Via Benzinga
News headline image
Analyst Scoreboard: 5 Ratings For Twist Bioscience ↗
 
Via Benzinga
News headline image
4 Analysts Have This To Say About Twist Bioscience ↗
 
Via Benzinga
News headline image
Twist Bioscience Earnings Preview ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Amgen Posts Upbeat Results, Joins OneSpan, Paylocity Holding, MercadoLibre And Other Big Stocks Moving Higher On Friday ↗
 
Via Benzinga
News headline image
TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024 ↗
TWST stock results show that Twist Bioscience beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition ↗
Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future. 
Via InvestorPlace
News headline image
Cathie Wood's Ark Continues Tesla Stock Buying Spree, Acquires Over $14M Worth Of Shares Amid Dip ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed ↗
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ: 
Via Benzinga
News headline image
Is The Stock Market Ready To Plunge? The Warning Signs Are Here... ↗
Find out how to spot the exhaustion of demand and the bearish analogue you could refer to to anticipate the down move. 
Via Talk Markets
News headline image
7 Stocks Cathie Wood Is Still Loading Up On in Q1 ↗
You won't find many timid bets among the Cathie Wood stocks she believes will dramatically alter our future. 
Via InvestorPlace
News headline image
7 Sexy Stocks That Will Continue to Outperform in 2024 ↗
These outperforming stocks are prime candidates for increasing in value sharply this year and beyond. Discover the top picks. 
Via InvestorPlace
News headline image
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M ↗
 
Via Benzinga
Topics Artificial Intelligence
News headline image
Why Is DNA Synthesis Company Twist Bioscience Stock Trading Higher Today? ↗
Twist Bioscience reported Q1 2024 earnings, beating revenue guidance and increasing FY24 guidance. Shares are up 7.16%. 
Via Benzinga
News headline image
Earnings Scheduled For February 2, 2024 ↗
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion. 
Via Benzinga
News headline image
Twist Bioscience Corp Daily Investment Opportunity ↗
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries. 
Via Talk Markets
News headline image
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion ↗
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing... 
Via Benzinga
News headline image
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
News headline image
Biotech Playbook: Small Caps Show Momentum Peaking During ↗
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market. 
Via Talk Markets
News headline image
3 Genomics Stocks to Unlock the Future of Medicine ↗
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use. 
Via InvestorPlace
News headline image
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout ↗
While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same. 
Via Talk Markets
News headline image
Biotech Is Coming Back, Can The Run Last? ↗
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. 
Via Talk Markets
News headline image
Five Best Performing Stocks Of The Top ETF Of November ↗
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way. 
Via Talk Markets
Topics ETFs
News headline image
Cramer Says No To This EV Maker, But Recommends This Major Automaker Stock: It 'Goes Up And Up' ↗
On CNBC’s "Mad Money Lightning Round," Jim Cramer said no to Lucid Group, Inc. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.